Risk for Lower Limb Amputation in Concomitant PAD and MVD
Microvascular disease was found to be associated with lower limb amputation, a risk increased in a synergistic manner in individuals with comorbid PAD.
Microvascular disease was found to be associated with lower limb amputation, a risk increased in a synergistic manner in individuals with comorbid PAD.
Carotid intima-media thickness and diastolic blood pressure were found to have minimal involvement in the mediation of the association between BMI and osteoarthritis.
Severe renal arteriosclerosis in diagnostic lupus nephritis biopsies is associated with 9-fold higher odds of atherosclerotic cardiovascular disease.
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.
Results of this study contradict the currently held paradigm of stenosis-related CVD risk.
VCAM-1 has been implicated in the pathogenesis of heart failure with preserved ejection fraction (HFpEF), but what is the association of VCAM-1 with development of clinically overt heart failure (HF) across ejection fraction categories?
The presence of calcified coronary atherosclerotic plaque morphology was found to predict all-cause and cardiovascular mortality among patients with coronary artery disease.
For patients with rheumatoid arthritis (RA), immunoreactivity against Aggregatibacter actinomycetemcomitans serotype b (anti-Aa) and Aa leukotoxin A (anti-LtxA) is associated with atherosclerosis.